Skip to main content
. 2014 Jan 8;14(Suppl 1):S2. doi: 10.1186/1471-2334-14-S1-S2

Table 1.

Viral vectored booster vaccines

Vaccine Name Composition Primary type Development phase
MVA85A Modified Vaccinia virus Ankara expressing Ag85A Booster vaccine Phase 2b

Ad5Ag85A Recombinant adenovirus 5 expressing Ag85A Booster vaccine Phase 1

Ad35 Recombinant adenovirus 35 expressing Ag85A-Ag85B-TB10.4 fusion protein Booster vaccine Phase 1/2